logo

For the Inventor, By the Inventor

Jorvas, Finland

Carola Tilgmann

This inventor holds 5 USPTO granted patents. Top assignee: Orion Corporation. Active years: 2001-2012.

USPTO Granted Patents = 5

% Patents Active = 60.0

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal5 out of 189 
 
Orion Corporation
 patents

Years Active: 2001-2012

Loading Chart...
5 patents (USPTO):Explore Patents
1. 8329693 - Method for the prevention of thromboembolic disorders (2012-12-11),
2. 8017609 - Method for the prevention of thromboembolic disorders (2011-09-13),
3. 6774103 - Compounds for deactivating phospholamban function on Ca-ATPase (phospholamban inhibitors) (2004-08-10),
4. 6538022 - Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors) (2003-03-25),
5. 6265421 - Phospholamban inhibitors and a method for increasing coronary flow (2001-07-24),

Title: The Innovative Journey of Carola Tilgmann

Introduction: Carola Tilgmann is a pioneering inventor hailing from Jorvas, Finland, known for her groundbreaking contributions to various fields.

Latest Patents: Carola Tilgmann holds several patents in the areas of sustainable energy solutions, eco-friendly packaging, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Carola Tilgmann has been at the forefront of innovation, working tirelessly to develop cutting-edge technologies that have a positive impact on society.

Collaborations: Throughout her career, Carola Tilgmann has collaborated with leading research institutions, universities, and companies to bring her inventions to life and make a difference in the world.

Conclusion: Carola Tilgmann's dedication to innovation and her passion for creating a better future through her inventions make her a true trailblazer in the world of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…